Ad
ALXO Quote Trading Chart ALX Oncology Holdings Inc.
home / stock / alxo / alxo quote
Quote | ALX Oncology Holdings Inc. (NASDAQ:ALXO)
| Last: | $1.55 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.66 |
| Close: | $1.55 |
| High: | $1.81 |
| Low: | $1.545 |
| Volume: | 1,487,126 |
| Last Trade Date Time: | 12/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
ALXO Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $1.55 | $1.66 | $1.55 | $1.81 | $1.545 | 1,487,126 | 12-03-2024 |
| $1.66 | $1.48 | $1.66 | $1.69 | $1.47 | 1,598,929 | 12-02-2024 |
| $1.48 | $1.53 | $1.48 | $1.57 | $1.4505 | 290,646 | 11-29-2024 |
| $1.51 | $1.52 | $1.51 | $1.53 | $1.4716 | 330,462 | 11-28-2024 |
| $1.51 | $1.52 | $1.51 | $1.53 | $1.4716 | 330,462 | 11-27-2024 |
| $1.49 | $1.48 | $1.49 | $1.55 | $1.47 | 550,419 | 11-26-2024 |
| $1.47 | $1.43 | $1.47 | $1.595 | $1.43 | 1,117,811 | 11-25-2024 |
| $1.41 | $1.27 | $1.41 | $1.44 | $1.27 | 968,927 | 11-22-2024 |
| $1.29 | $1.22 | $1.29 | $1.33 | $1.21 | 449,390 | 11-21-2024 |
| $1.21 | $1.22 | $1.21 | $1.2496 | $1.21 | 580,034 | 11-20-2024 |
| $1.23 | $1.22 | $1.23 | $1.265 | $1.19 | 922,010 | 11-19-2024 |
| $1.22 | $1.27 | $1.22 | $1.3 | $1.21 | 1,681,073 | 11-18-2024 |
| $1.29 | $1.35 | $1.29 | $1.35 | $1.25 | 573,890 | 11-15-2024 |
| $1.33 | $1.33 | $1.33 | $1.38 | $1.325 | 1,387,384 | 11-14-2024 |
| $1.34 | $1.35 | $1.34 | $1.41 | $1.295 | 1,022,290 | 11-13-2024 |
| $1.34 | $1.47 | $1.34 | $1.5 | $1.34 | 983,869 | 11-12-2024 |
| $1.48 | $1.5 | $1.48 | $1.575 | $1.47 | 738,507 | 11-11-2024 |
| $1.45 | $1.55 | $1.45 | $1.63 | $1.44 | 917,803 | 11-08-2024 |
| $1.51 | $1.53 | $1.51 | $1.555 | $1.4505 | 808,133 | 11-07-2024 |
| $1.53 | $1.54 | $1.53 | $1.57 | $1.44 | 739,318 | 11-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
ALX Oncology Holdings Inc. Company Name:
ALXO Stock Symbol:
NASDAQ Market:
ALX Oncology Holdings Inc. Website:
Ad
-
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend p...
-
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend p...
-
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend p...